HIV-1 Therapies
Oct 29, 2021
Changing Dynamics of HIV-1 Treatment Market
The HIV-1 treatment market for naïve and experienced patients is evolving consistently. Some of the major changes include the preference of single-tablet regimens (STRs) over multiple tablet regimens (MTRs), tenofovir alafenamide (TAF)-based therapies over tenofovir disoproxil fumarate (TDF)-based therapies, integr...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
